Is Illumina a monopoly?
Table of Contents
Illumina currently has a monopoly on the NGS space. The company has somehow managed to successfully eliminate most of their competition in the sequencing market.
What exactly does Illumina do?
Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine.
What is Illumina DNA sequencing?
Illumina next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain.
Who owns Illumina?
Francis deSouza
Illumina, Inc.
| Type | Public |
|---|---|
| Headquarters | San Diego, California , U.S. |
| Key people | Francis deSouza (President & CEO) John W. Thompson ( Board Chair) Sam Samad (CFO) |
| Products | NovaSeq 6000, HiSeq X, HiSeq 4000, MiSeq, MiSeqDx, MiniSeq, iSeq 100, NextSeq 550, NextSeq 550Dx, iScan |
What is AgriGenomics?
Agricultural genomics (AgriGenomics) is the application of genomics in agriculture to improve the productivity and sustainability in crop and livestock production.
Will Illumina get Grail?
Illumina, the global leader in DNA sequencing, first announced its intention to acquire GRAIL nearly a year ago, reuniting Illumina with GRAIL four years after it was spun off….
| Exhibit A Net Consideration (unaudited) | ||
|---|---|---|
| (-) Illumina Holdings (a) | (1.4) | (0.4) |
| GRAIL Shareholders (excluding Illumina) | 9.9 | 3.1 |